A real-world analysis of tyrosine receptor kinase inhibitor-related toxicities in cancer treatment.

Li, Wenjie; Wen, Keshan; Zhu, Weijie; Luo, Shangfei

Li, Wenjie; Wen, Keshan; Zhu, Weijie; Luo, Shangfei.

Afiliação

Li W; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Wen K; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Zhu W; Department of Neurology, The Third Affiliated Hospital of Southern Medical University, 183 Zhongshan Avenue West, Tianhe District, Guangzhou, Guangdong, 510630, China.
Luo S; The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

Per Med ; 20(6): 485-491, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37909303

Assuntos

Neoplasias; Humanos; Neoplasias/tratamento farmacológico; Estudos Retrospectivos; Receptores Proteína Tirosina Quinases; Inibidores de Proteínas Quinases/efeitos adversos

Palavras-chave

FAERS; TRK inhibitor; cancer; safety; toxicity profile

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Per Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google